US$ 21.97
nestle glp 1 products may complement GLP-1 weight-loss drugs Nestle tweaks products to appeal
Description
In terms of side effects and tolerability, the advantage goes to neither (comparable)

The platform is still building its reputation, so reviews are limited, but early patient feedback has been positive

GLP-1, Metformin & Rapamycin: a primer A fact-based review of three treatments that may (or may not) help you age slower

Sci Rep 2024

, & Thyfault, J

At the end of the study, patients who had metabolic surgery had a: 32% lower risk of death 35% lower risk of major heart problems (such as heart attack, heart failure, or stroke) 47% lower risk of serious kidney disease 54% lower risk of diabetes-related eye damage (retinopathy) On average, people who had metabolic surgery lost 21.6% of their body weight over 10 years, compared with 6.8% weight loss in people who took GLP-1 medicines
